T0	Outcomes 0 20	Age-related response
T1	Outcomes 113 132	efficacy and safety
T2	Outcomes 443 467	Anti-PRP antibody levels
T3	Outcomes 550 570	Immunoresponsiveness
T4	Outcomes 588 597	increased
T5	Outcomes 610 641	lower incidence of side effects
T6	Outcomes 747 803	well tolerated clinically and has greater immunogenicity